Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,274 INR | -1.69% | -6.04% | -6.05% |
05-06 | Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India | MT |
04-16 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.05% | 1.18B | |
+18.67% | 43.74B | |
+24.13% | 22.26B | |
+16.41% | 14.9B | |
+9.03% | 13.39B | |
+40.48% | 12.12B | |
-9.36% | 6.92B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.47B |
- Stock Market
- Equities
- 524742 Stock
- News Caplin Point Laboratories Limited
- Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution